Cardiac Conduction System Disease
Recent clinical, regulatory, research and industry developments relating to this disease.
Cardiac pacing and lead devices management: 25 years of research at EP Europace journal.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes3
- Cardiac Pacing, Artificial1
- Cardiac Resynchronization Therapy1
- Pacemaker, Artificial1
Leading journals1
- Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2
Leading researchers8
- Auricchio A1
- Biffi M1
- Boveda S1
- Burri H1
- Defaye P1
- El-Chami M1
- Ellenbogen KA1
- Glikson M1
Affiliations (unnormalised)6
- Aston University1
- Cardiovascular Research Institute Maastricht (CARIM)1
- Clinical and Experimental Medicine PhD Program1
- Duke University1
- Emory University School of Medicine1
- IRCCS Azienda Ospedaliero-Universitaria di Bologna1
Reference
Authoritative identity, definition & identifiers.
Diseases characterized by pathological irregularities in the HEART CONDUCTION SYSTEM. They may be associated with other heart diseases and syndromes (e.g., BRUGADA SYNDROME; NEUROMUSCULAR DISEASE, HEART BLOCKS), isolated or may result from injuries. You can have a conduction disorder without having an arrhythmia, but some arrhythmias arise from conduction disorders. OMIM: 601144.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.